Health Care · Pharmaceutical Preparations · OTC · CIK 1743344 · FYE Dec 31 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $0.13Day −4.94%Mkt cap $22M1Y −56.7%Off 52W high −76.2%Vol (1Y) 95.6%
Daily closing price, split-adjusted to the current basis; 2.7y shown of 673 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest0.5% of sh out |
| Days to cover41.7d |
| Top-10 13F concentration100.0% |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)CAD 19.0M |
| Earnings (TTM)-CAD 32.2M |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (CAD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−43.9% |
| 1Y−56.7% |
| Since incept. (ann.)−32.6% |
Total return through 2026-07-29 · series begins 2023-11-16. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)95.6% |
| Ann. volatility (3Y)79.5% |
| Sharpe (1Y)−0.42 |
| Sharpe (3Y)−0.12 |
| Max drawdown (1Y)−74.6% |
| Max drawdown (3Y)−84.0% |
| Beta (3Y vs SPY)−1.63 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 100,000 | $39,890 | 0.06% | new |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
No reported quarters on file for PYRGF.
